WORLD UNIVERSITY DIRECTORY
Medical Education MedPage Today Neurology

  Back to "News Updates - Homepage"


| More


MedPage Today Neurology - Recent Educational Updates

-->
As Dementia Rates Increase, Experts Warn Hospital Emergency Rooms Are Underprepared
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115166.jpg"/> (MedPage Today) -- AURORA, Ill. -- At her mother's home in Illinois, Tracy Balhan flips through photos of her dad, Bill Speer. In one picture, he's smiling in front of a bucket of sweating beers and wearing a blue T-shirt that reads, "Pops. The...


Hearing Loss and Heart Failure; Improved TAVR Outcomes
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115190.jpg"/> (MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center...


Hearing Loss May Play a Bigger Role in Dementia Than Previously Thought
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115179.jpg"/> (MedPage Today) -- Hearing loss may play a bigger role in dementia than previously thought, data from a U.S. cohort study suggested. In a sample of nearly 3,000 older adults, up to 32% (95% CI 11.0%-46.5%) of incident dementia over 8 years could...


Is Trump Getting Guideline-Recommended Care for Cardiac Risk?
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115157.jpg"/> (MedPage Today) -- After findings from President Trump's annual physical exam were released last week, observers were struck by the persistent aspirin use recorded in the doctor's report. Trump, 78, has no apparent history of cardiovascular disease...


RFK Jr.'s Plans on Autism Include Studying Potential Environmental Risks
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115156.jpg"/> (MedPage Today) -- WASHINGTON -- HHS Secretary Robert F. Kennedy Jr. warned that children in the U.S. are being diagnosed with autism at an "alarming rate," promising on Wednesday to conduct exhaustive studies to identify any environmental factors...


Autism Rates Hit Record High, CDC Data Show
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115143.jpg"/> (MedPage Today) -- U.S. autism rates reached a record high, with about one in 31 children identified with autism spectrum disorder (ASD) in 2022, new CDC data suggested. The prevalence of ASD among children 8 years old was higher in 2022 than...


Your Father's Alzheimer's; Autism Gut-Brain Axis; New Parkinson's Genes Uncovered
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115134.jpg"/> (MedPage Today) -- Cognitively unimpaired people whose fathers had Alzheimer's disease had a stronger link between global amyloid-beta and tau deposition than those whose mothers had Alzheimer's, a cohort study suggested. (Neurology) New research...


Read the Results of Trump's 2025 Physical Exam
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115125.jpg"/> (MedPage Today) -- On April 11, 2025, President Donald J. Trump underwent his annual physical examination at Walter Reed National Military Medical Center. I performed and supervised the comprehensive exam, which included diagnostic and laboratory...


The Choice Between Chemotherapy and Targeted Therapy in Pediatric Low-Grade Glioma
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115124.jpg"/> (MedPage Today) -- In this fourth and final installment of MedPage Today's virtual roundtable series on pediatric low-grade glioma, moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, is joined once again by Sabine...


Emergency Care for Cannabis Use Tied to Higher Dementia Risk
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115116.jpg"/> (MedPage Today) -- People who required emergency department (ED) or acute hospital care for cannabis use may have an increased risk of a subsequent dementia diagnosis, a retrospective matched cohort study of 6 million people in Canada suggested...


Another Push for Upfront Ezetimibe-Statin Combo Soon After MI
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115113.jpg"/> (MedPage Today) -- Adding ezetimibe (Zetia) therapy to statins early after a heart attack improved outcomes, Swedish national records suggested. With statins almost universally used in this setting, people who also got upfront ezetimibe in the...


Tolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple Sclerosis
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115108.jpg"/> (MedPage Today) -- SAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple sclerosis (SPMS), the phase III HERCULES trial showed. The Bruton's tyrosine kinase (BTK...


Screening for Depression and Anxiety in Multiple Sclerosis
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115106.jpg"/> (MedPage Today) -- Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or untreated. A machine learning model may help by analyzing routinely collected clinical information to serve...


Pridopidine Shows Promise in Subgroup of Huntington's Patients
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115099.jpg"/> (MedPage Today) -- SAN DIEGO -- Treatment with investigational pridopidine seemed to offer benefits for certain patients with Huntington's disease, according to subgroup analysis of the PROOF-HD trial. Those improvements were seen in terms of...


Anti-CGRP Drug Reduces Episodic Migraine in Kids
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115096.jpg"/> (MedPage Today) -- SAN DIEGO -- Fremanezumab (Ajovy) cut monthly migraine days in children and adolescents with episodic migraine, according to the SPACE trial. The phase III study showed a reduction in monthly migraine days in patients (mean...


Targeted Treatment Improves Disability in Guillain-Barre Syndrome
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115094.jpg"/> (MedPage Today) -- SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barr&#233; syndrome (GBS), a phase III, placebo-controlled study...


Healthy Aging and Diet; Global Effect of Cardiovascular Risk Factors
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115087.jpg"/> (MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center...


Narcolepsy-CVD Link: Stage Is Set as Early as Childhood
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115085.jpg"/> (MedPage Today) -- The link between narcolepsy and cardiovascular disease (CVD) was strengthened by new evidence that the relationship applied to subclinical disease and was apparent early in life, based on a retrospective cohort study. Across...


AXS-12 Reduces Cataplexy, Sleepiness in Narcolepsy
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115078.jpg"/> (MedPage Today) -- SAN DIEGO -- AXS-12 (reboxetine), an investigational treatment for narcolepsy, reduced weekly cataplexy attacks and in some cases provided complete remission, the phase III SYMPHONY study showed. From baseline, patients treated...


RFK Jr. Says HHS Will Determine the Cause of Autism by September
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115073.jpg"/> (MedPage Today) -- The nation's top health agency will undertake a "massive testing and research effort" to determine the cause of autism, HHS Secretary Robert F. Kennedy Jr. announced Thursday. Kennedy, a longtime vaccine critic who has pushed...


Benefits in Myasthenia Gravis Extend to 52 Weeks With Inebilizumab
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115051.jpg"/> (MedPage Today) -- SAN DIEGO -- Inebilizumab (Uplizna) improved function and reduced disease severity for up to 52 weeks in generalized myasthenia gravis (gMG) patients who were acetylcholine receptor (AChR) antibody-positive, data from the MINT...